KeeleCANeilESamson Wright's Applied Physiology, 12th edn.Oxford: University Press, 1978: 411–21
4.
TubergenDGNeoplastic diseases. In: KempeCHSilverHKO'BrienDFulginitiVA, eds. Current Paediatric Diagnosis and Treatment, 9th edn.New York: Lange, 1985: 974–7
5.
YokomoriKHoriTTsuchidaYKurodaMYoshiodaMA new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA. J Pediatr Surg1989; 24: 391–4
6.
SandlerMRuthvenCRJColorimetric estimation of 3-methoxy-4-hydroxymandelic acid in urine. Lancet1959; ii: 1034
7.
GitlowSEMendlowitzMWilkEKWilkSWolfRLBertaniLMExcretion of catecholamine metabolites by normal children. J Lab Clin Med1968; 72: 612–20
8.
PisanoJJCroutJRAbrahamDDetermination of 3-methoxy-4-hydroxymandelic acid in urine. Clin Chim Acta1962; 7: 285–91
9.
FeliceLJKissingerPTA modification of the Pisano method for vanilmandelic acid using high pressure liquid chromatography. Clin Chim Acta1977; 76: 317–20
10.
DavidsonDFSimultaneous assay for urinary 4-hydroxy-3-methoxymandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid by isocratic HPLC with ECD. Ann Clin Biochem1989; 26: 137–43
11.
TuchmanMCrippinPJKrivitWCapillary gas-chromatography determination of urinary homovanillic acid and vanillylmandelic acid. Clin Chem1983; 29: 828–31
12.
Leiendecker-FosterCFreierEFImproved simultaneous gas chromatographic analysis for homovanillic acid and vanillylmandelic acid in urine. Clin Chem1981; 27: 2029–32
13.
TaylorGFDuongTCarterNGAn improved gas chromatographic determination of urinary catecholamine metabolites. Ann Clin Biochem1983; 20: 289–93
14.
SeviourJAMcGillACDaleGCraftAWMethod of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography—mass spectrometry suitable for neuroblastoma screening. J Chromatogr1988; 432: 273–7
15.
YoshiokaMAsoCAmanoJTamuraZSugiMKurodaMPreparation of monoclonal antibodies to vanilmandelic acid and homovanillic acid. Biogenic Amines1987; 4: 229–35
16.
KawaguchiSHirachiNFukamachiMNew analyser for the determination of urinary vanillylmandelic acid, homovanillic acid and creatinine. J Chromatogr1991; 567: 11–19
17.
Von EulerUSHambergUColorimetric determination of noradrenaline and adrenaline. Acta Physiol Scand1949; 19: 74
18.
NatelsonSLugovoyJRPincusJBA new fluorometric method for the determination of epinephrine. Arch Biochem Biophys1949; 23: 157
19.
KagedalBGoldsteinDSCatecholamines and their metabolites. J Chromatogr1988; 429: 177–233
20.
DavidsonDFFitzpatrickJA simple, optimised and rapid assay for urinary free catecholamines by HPLC with electrochemical detection. Ann Clin Biochem1985; 22: 297–303
21.
ParkerNCLevtzowCBWrightPWWoodardLLChapmanJFUniform chromatographic conditions for quantifying urinary catecholamines, metanephrines, vanillylmandelic acid, 5-hydroxyindoleacetic acid, by liquid chromatography, with electrochemical detection. Clin Chem1986; 32: 1473–6
22.
PeastonRTRoutine determination of urinary free catecholamines by high-performance liquid chromatography with electrochemical detection. J Chromatogr1988; 424: 263–72
23.
AndersonGMDurkinTAMortonJBCohenDJLiquid chromatographic determination of urinary catecholamines after one-step alumina extraction. J Chromatogr1988; 424: 373–7
24.
GreenBCooperJDHTurnellDCAn automated method for the analysis of urinary free catecholamines using ASTED and high-pressure liquid chromatography. Ann Clin Biochem1989; 26: 361–7
25.
MoyerTPNai-SiangJTyceGHShepsSGAnalysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem1979; 25: 256–63
26.
JackmanGPDifferential assay for urinary catecholamines by use of liquid chromatography with fluorescence detection. Clin Chem1981; 27: 1202–4
27.
SekiTYanagiharaYNoguchiKDetermination of free catecholamines in human urine by direct injection of urine into a liquid chromatographic column-switching system with fluorometric detection. J Chromatogr1990; 515: 435–40
28.
AntonAHSayreDFA study of the factors affecting the aluminium oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther1962; 138: 360–75
29.
WesterinkBHCBaskerFJO'HanlonJFUse of alumina, Sephadex G10, and ion-exchange columns to purify samples for determination of epinephrine, norepinephrine, dopamine, homovanillic acid, and 5-hydroxyindoleacetic acid in urine. Clin Chem1982; 28: 1745–8
30.
WuAHBGornetTGPreparation of urine samples for liquid chromatographic determination of catecholamines: bonded phase phenylboronic acid, cation-exchange resin, and alumina absorbents compared. Clin Chem1985; 31: 298–302
31.
ErikssonBMWikstromMDetermination of catecholamines in urine by liquid chromatography and electrochemical detection after on-line sample purification on immobilized boronic acid. J Chromatogr1992; 593: 185–90
32.
MuskietFAKemaIPSensitivity and specificity of urinary N-acetyldopamine as a marker for neuroblastomas: comparison with traditional urinary catecholamines metabolites. J Chromatogr1992; 579: 184–8
33.
JouveJHeraultJTournadeHMuhJPDetermination by high-performance liquid chromatography with electrochemical detection of free and conjugated N-acetyldopamine excretion in urine of children with neuroblastoma and nephroblastoma. J Chromatogr1992; 574: 9–15
34.
CarlsenNLNeuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening. Am J Pediatr Hematol Oncol1992; 14: 103–10
35.
HuddartSNMuirKRParkesSMannJRStevensMCRaafatFNeuroblastoma: A 32 year population based study—implications for screening. Med Pediatr Oncol1993; 21: 96–102
36.
NishiMMiyakeHTakedaTTakasugiNHanaiJKawaiTUrinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for mass screening of neuroblastoma. Jpn J Clin Oncol1990; 20: 268–70
37.
NishiMMiyakeHTakedaTKikuchiYHanaiJYonemoriHMass screening of neuroblastoma in Sapporo City, Japan. Am J Pediatr Hematol Oncol1992; 14: 327–31
38.
SawadaTPast and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol1992; 14: 320–6
39.
SawadaTMatsumuraTKawakatsuHSugimotoTKurodaHHosoiHLong term effects of mass screening for neuroblastoma in infancy. Am J Pediatr Hematol Oncol1991; 13: 3–7
40.
CarlsenNLHow frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer1990; 61: 441–6
41.
TuchmanMRamnaraineMRWoodsWGKrivitWThree years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics1987; 79: 203–5
O'MearaATormeyWPFitzGeraldRJFitzgibbonMCKennyDInterpretation of random urinary catecholamines and their metabolities in neuroblastoma. Acta Paediatr Scand (in press)
44.
NishiMMiyakeHTakedaTYamashiroKTakasugiNHanaiJFluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma. Eur J Pediatr1990; 149: 859–61
45.
HaymondREKnightJABillsACNormal values for urinary 3-methoxy-4-hydroxymandelic acid (VMA) in children. Clin Chem1978; 24: 1853–4
46.
SoldinSJHillJGLiquid-chromatographic analysis for urinary 4-hydroxy-3-methoxymandelic acid and 4-hydroxy-3-methoxyphenylacetic acid and its use in investigation of neural crest tumours. Clin Chem1981; 27: 502–3
47.
TuchmanMMorrisCLRamnaraineMLBowersLDKrivitWValue of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: Comparison with 24 hour urine collections. Pediatrics1985; 75: 324–8
48.
ItoSKatoTMarutaKJimbowKFujitaK“Total” acidic metabolites of catecholamines in urine as determined by hydrolysis with hydriodic acid and liquid chromatography: Application to patients with neuroblastoma and melanoma. Clin Chem1985; 31: 1185–8
49.
Premel-CabicATurcantAAllainPNormal reference intervals for free catecholamines and their acid metabolites in 24 hour urines from children, as determined by liquid chromatography with amperometric detection. Clin Chem1986; 32: 1585–7
50.
KellieSJClagueAEMcGearyHMSmithPJThe value of catecholamine metabolite determination in untimed urine collections in the diagnosis of neural crest tumours in children. Aust Paediatr J1986; 22: 313–5
51.
WorthingtonDJHammondEMEldeebBBGreenAAddisonGMMorrisJones PHNeuroblastoma—when are urinary catecholamines and their metabolites ‘normal’?Ann Clin Biochem1988; 25: 620–6
52.
WaltersEGProctorDGElderGHWaltersGUrinary excretion of HMMA in children. Ann Clin Biochem1989; 26: 44–8
53.
HendersonMJHeneyDMcGinlayJMLewisIBaileyCMeasurement of dopamine, HVA and HMMA in untimed urine samples; establishment of age related reference range data in children. Ann Clin Biochem1992; 29: 162–7
54.
FitzgibbonMCFitzGeraldRJTormeyWPO'MearaAKennyDReference values for urinary HMMA, HVA, noradrenaline, adrenaline and dopamine excretion in children using random urine samples and HPLC with electrochemical detection. Ann Clin Biochem1992; 29: 400–4
55.
De SchaepdryverAFHooftCDelbekeM-JVan den NoortgaeteMUrinary catecholamines and metabolites in children. J Pediatr1978; 93: 266–8
56.
DalmazYPeyrinLSannLDutrugeJAge related changes in catecholamine metabolites of human urine from birth to adulthood. J Neural Transm1979; 46: 153–74
57.
ProkopczykJWankowiczBWenzelEUrinary excretion of catecholamines and their metabolites in children with neuroblastoma. Pediatr Pol1979; 8: 853–9
58.
ParraARamirez delAngel ACervantesCSanchezMUrinary excretion of catecholamines in healthy subjects in relation to body growth. Acta Endocrinol1980; 94: 546–51
59.
RosanoTGLiquid-chromatographic evaluation of age related changes in the urinary excretion of free catecholamines in paediatric patients. Clin Chem1984; 30: 301–3
60.
ReedPBu'lockDJonesALaytonTReference ranges for free catecholamines/creatinine ratios in random urines from normal children aged 5 to 16 years. Ann Clin Biochem1991; 28: 297–8
61.
RiddhimatRPrabhantCSirisaliKTangvarasithichaiOPoosiriAComparative study of vanillylmandelic acid in random and 24 h urine coUections. J Med Assoc Thai1990; 73: 239–43
62.
LaBrosseEHCom-NougueCZuckerJ-MComoyEBohuonCLemerleJUrinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumours. Cancer Res1980; 40: 1995–2001
63.
Van AckerBACKoomenGCMKoopmanMGde WaartDRAriszLCreatinine clearance during cimetidine administration for the measurement of glomerular filtration rate. Lancet1992; 340: 1326–9
64.
AltmanDGConstructing a normal range. Clin Chem1979; 25: 492–3
65.
SolbergHEApproved recommendations (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta1987; 170: S13–32
66.
AltmanDGGoreSMGardnerMJPocockSJStatistical guidelines for contributors to medical journals. Ann Clin Biochem1992; 29: 1–8
